Immunohistochemical analysis of resected clinical stage I pulmonary adenocarcinomas with high preoperative levels of serum carcinoembryonic antigen

Annals of Thoracic Surgery

Volumn 76, Issue 1, 2003, Pages 203-207

  Sawabata, Noriyoshi ^a,b   Hirano, Hiroshi ^a   Inoue, Masayoshi ^a   Okumura, Yoshitomo ^a   Asada, Hiroki ^a   Takeda, Shin Ichi ^a   Maeda, Hajime ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CLASSIFICATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; STAINING; SURVIVAL RATE;

ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0037662161     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00132-2     Document Type: Article

References (24)

1. Vincent RG, Chu TM, Fergen TB, Ostrander M. Carcinoembrionic antigen in 228 patients with carcinoma of the lung. Cancer 1975;36:2069-76.
2. Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y, et al. Serial plasma carcinoembrionic antigen measurment for monitoring patients with advanced lung cancer during chemotherapy. Cancer 1986;57:1318-23.
3. Nisman B, Amir G, Lafair J, et al. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. Anticancer Res 1999;19:3549-52.
4. Concannon JP, Dalbow MH, Hodgson SE, et al. Prognostic value of preoperative carcinoembryonic antigen CEA) plasma levels in patients with bronchogenic carcinoma. Cancer 1978;42:1477-83.
5. Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Anticancer Res 1999; 19:3613-8.
6. Diez M, Torres A, Maestro ML, et al. Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer. Br J Cancer 1996;73:1248-54.
7. Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. Anticancer Res 2000;20: 2177-80.
8. Yanagi S, Sugiura H, Morikawa T, Kaji M, Okushiba S, Kondo S, Katoh H. Tumor size does not have prognostic significance in stage Ia NSCLC. Anticancer Res 2000;20: 1155-8.
9. Icard P, Regnard JF, Essomba A, Panebianco V, Magdeleinat P, Levasseur P. Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 1994;58:811-4.
10. Rubins JB, Dunitz J, Rubins HB, et al. Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 1998;116:412-6.
11. Suzuki K, Nagai K, Yoshida J, et al. Prognostic factoes in clinical stage I non-small cell lung cancer. Ann Thorac Surg 1999;67:927-32.
12. Sawabata N, Hota M, Takeda S, Okumura Y, Asada T, Maeda H. Serum carcinoembryonic antigen (CEA) level in surgically resected clinical-stage I patients with non-small cell lung cancer (NSCLC). Ann Thorac Surg 2002;74:174-9.
13. Yamanishi H, Hayakawa M, Nakano N, Ohshima S, Kotake Y, Yasumitsu T, et al. Carcinoembryinic antigen in resected cases with lung cancer-postoperative variation and recurrence. Haigan 1988;28:723-9.
14. Minami H, Tsubota N, Yoshimura M, et al. Analysis of carcinoembryonic antigen (CEA) level in pulmonary adeno-carcinoma-changes in CEA levels and survival. Jpn J Resp Surg 1998;12:766-71.
15. Tokunaga N, Kijima H, Noto T, et al. Immunohistochemical localization of carcinoembryonic antigen as a predictor of lymph node status in submucosa-invasive colorectal carcinoma. Dis Colon Rectum 1995;38:842-7.
16. Kim JC, Han MS, Lee HK, et al. Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma. Dis Colon Rectum 1999;42:640-8.
17. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F. Carcinoembryonic antigen staining patterns at the invasive tumor margin predict the malignant potential of colorectal carcinoma. Oncology 1994;51: 228-33.
18. Koshiji M, Ogura E, Takada H, Kawanishi H, Ikehara S, Hioki K. Clinicopathologic and immunohistochemical analyses in lung metastasis of colorectal carcinoma. Oncol Rep 1998;5:811-5.
19. Wiggers T, Arends JW, Vertinen C, Moerkerk PM, Bosman FT. Prognostic significance of CEA immunoreactivity patterns in large bowel carcinoma tissue. Br J Cancer 1986;54: 409-14.
20. Hamada Y, Yamamura M, Hioki K, Yamamoto M, Narura H, Watanabe K. Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Cancer 1985; 55:136-41.
21. Dent PB, McCulloch PB, Wesley-James O, MacLaren R, Muirhed W, Dunnett CW. Measurment of carcinoembryonic antigen in patients with bronchogenic carcinoma. Chest 1978;42:1484-91.
22. Yoshimatsu S, Miyoshi S, Maebeya S, et al. Analtsis of the early postoperative serum carcinoembryonic antigen time-couse as a prognostic tool for beonchogenic carcinoma. Cancer 1997;79:1533-40.
23. Pisters KM, Ginsberg RJ, Giroux DJ, et al. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. J Thorac Cardiovasc Surg 2000;119:429-39.
24. Ordonez C, Screaton RA, Ilantzis C, Stnners CP. Human carcinoembryonic antigen function as a general inhibitor of anoikis. Cancer Res 200;60:3419-24.